Auna S.A. (NYSE:AUNA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Key Points

• Consensus rating: Five analysts rate Auna an average of "Moderate Buy" (1 sell, 1 hold, 1 buy, 2 strong buys) with a mean 12‑month target price of $7.30.
• Recent analyst activity: Several firms have upgraded or initiated coverage—Zacks and Wall Street Zen moved to strong‑buy, HSBC to buy ($6.90 target), and Jefferies started coverage with a $9 objective—while Weiss maintained a sell rating, reflecting mixed views.
• Financials and institutional interest: Auna reported $0.53 EPS on $596.6M revenue last quarter, trades near a $391M market cap with a P/E of 14.68, and saw stake increases from funds including Marshall Wace, Goldman Sachs and Citadel.

Auna S.A. (NYSE:AUNA - Get Free Report) has earned an average rating of "Moderate Buy" from the five research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, one has assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year target price among brokers that have covered the stock in the last year is $7.30.

A number of equities analysts have recently commented on AUNA shares. Zacks Research upgraded Auna from a "strong sell" rating to a "strong-buy" rating in a research note on Monday, February 9th. HSBC upgraded Auna from a "hold" rating to a "buy" rating and set a $6.90 target price for the company in a research note on Wednesday, January 21st. Wall Street Zen raised Auna from a "buy" rating to a "strong-buy" rating in a research report on Saturday, February 28th. Weiss Ratings reiterated a "sell (d)" rating on shares of Auna in a report on Friday. Finally, Jefferies Financial Group started coverage on Auna in a research report on Friday, January 16th. They issued a "buy" rating and a $9.00 price objective for the company.

Institutional Trading of Auna

A number of hedge funds have recently bought and sold shares of the stock. Citadel Advisors LLC raised its position in shares of Auna by 28.9% during the third quarter. Citadel Advisors LLC now owns 36,352 shares of the company's stock valued at $244,000 after buying an additional 8,147 shares during the last quarter. Marshall Wace LLP lifted its position in shares of Auna by 391.0% in the 4th quarter. Marshall Wace LLP now owns 162,992 shares of the company's stock worth $802,000 after acquiring an additional 129,799 shares during the period. Goldman Sachs Group Inc. grew its holdings in shares of Auna by 43.1% during the 4th quarter. Goldman Sachs Group Inc. now owns 71,645 shares of the company's stock worth $352,000 after purchasing an additional 21,579 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of Auna during the fourth quarter valued at approximately $162,000. Finally, Heron Bay Capital Management acquired a new position in shares of Auna in the fourth quarter valued at $138,000.

Auna Price Performance

NYSE AUNA opened at $5.29 on Tuesday. Auna has a 1 year low of $4.46 and a 1 year high of $7.50. The company has a fifty day simple moving average of $5.16 and a 200 day simple moving average of $5.35. The company has a current ratio of 1.11, a quick ratio of 1.01 and a debt-to-equity ratio of 1.87. The company has a market cap of $391.22 million, a P/E ratio of 14.68 and a beta of 2.08.

Auna (NYSE:AUNA - Get Free Report) last announced its earnings results on Saturday, February 14th. The company reported $0.53 EPS for the quarter. The firm had revenue of $596.55 million for the quarter. Auna had a net margin of 2.13% and a return on equity of 19.23%. On average, sell-side analysts predict that Auna will post 0.5 EPS for the current year.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna's organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.